Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes

Table 2

Metabolic parameters of subjects in different groups.

Group	TC; (mmol/L)	TG; (mmol/L)	HDL-C; (mmol/L)	LDL -C; (mmol/L)	VLDL-C (mmol/L)	BUN; (mmol/L)	Cr; (umol/L)	UA; (umol/L)
Normal control	3.62 ± 0.76	1.26 ± 0.53	1.44 ± 0.23	2.42 ± 0.83	0.52 ± 0.07	4.20 ± 1.7	42.0 ± 5.7	204 ± 17
Simple obesity	4.67 ± 0.58^☆	1.56 ± 0.62^☆	1.35 ± 0.37^☆	2.46 ± 0.72	0.51 ± 0.03	3.96 ± 1.5	43.0 ± 3.2	212 ± 12
Type 2 diabetes
Nonobese	4.65 ± 0.61^☆	1.60 ± 0.66^☆☆	1.27 ± 0.35^☆☆	2.52 ± 0.57	0.71 ± 0.04^☆○	4.32 ± 0.8	46.0 ± 4.2	207 ± 16
Obese	5.21 ± 0.72^☆☆	2.31 ± 1.27^☆☆○○∆∆	0.95 ± 0.42^☆☆○○∆∆	2.83 ± 0.64^☆☆○○∆∆	0.74 ± 0.06^☆○	4.48 ± 0.6	43.0 ± 5.0	215 ± 27

TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; VLDL-C: very low-density lipoprotein; BUN: blood urea nitrogen; Cr: creatinine; UA: uric acid. Data are mean ± SD or median. ^☆ < 0.05, ^☆☆ < 0.01 versus normal control; ^○ < 0.05, ^○○ < 0.01 versus simple obese group; ^∆∆ < 0.01 versus nonobese diabetic group.